3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Lymphoma, Follicular
5
Lymphoma
4
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma, B-Cell
3
Lymphoma, Large B-Cell, Diffuse
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Diseases
1
Graft vs Host Disease
1
Dendritic Cell Sarcoma, Interdigitating
1
Bronchiolitis Obliterans Syndrome
1
Anemia
1
Interventions
Brentuximab Vedotin
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Vinblastine
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Doxorubicin
1
Dacarbazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Hodgkin Disease
×
Rituximab
×
Clear all
No trials found.